Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 325 entries
Sorted by: Best Match Show Resources per page
Effect of Flos carthami Extract and α 1-Adrenergic Antagonists on the Porcine Proximal Ureteral Peristalsis.

Evidence-based complementary and alternative medicine : eCAM

Wu SY, Man KM, Shen JL, Chen HY, Chang CH, Tsai FJ, Hsieh WT, Winardi D, Lee YJ, Tsai KS, Lin YN, Chen YH, Chen WC.
PMID: 25170340
Evid Based Complement Alternat Med. 2014;2014:437803. doi: 10.1155/2014/437803. Epub 2014 Jul 09.

Traditional Chinese medicine (TCM) has been proposed to prevent urolithiasis. In China, Flos carthami (FC, also known as Carthamus tinctorius) (Safflower; Chinese name: Hong Hua/) has been used to treat urological diseases for centuries. We previously performed a screening...

Cite
Wu SY, Man KM, Shen JL, et al. Effect of Flos carthami Extract and α 1-Adrenergic Antagonists on the Porcine Proximal Ureteral Peristalsis. Evid Based Complement Alternat Med. 2014;2014:437803doi: 10.1155/2014/437803.
Wu, S. Y., Man, K. M., Shen, J. L., Chen, H. Y., Chang, C. H., Tsai, F. J., Hsieh, W. T., Winardi, D., Lee, Y. J., Tsai, K. S., Lin, Y. N., Chen, Y. H., & Chen, W. C. (2014). Effect of Flos carthami Extract and α 1-Adrenergic Antagonists on the Porcine Proximal Ureteral Peristalsis. Evidence-based complementary and alternative medicine : eCAM, 2014437803. https://doi.org/10.1155/2014/437803
Wu, San-Yuan, et al. "Effect of Flos carthami Extract and α 1-Adrenergic Antagonists on the Porcine Proximal Ureteral Peristalsis." Evidence-based complementary and alternative medicine : eCAM vol. 2014 (2014): 437803. doi: https://doi.org/10.1155/2014/437803
Wu SY, Man KM, Shen JL, Chen HY, Chang CH, Tsai FJ, Hsieh WT, Winardi D, Lee YJ, Tsai KS, Lin YN, Chen YH, Chen WC. Effect of Flos carthami Extract and α 1-Adrenergic Antagonists on the Porcine Proximal Ureteral Peristalsis. Evid Based Complement Alternat Med. 2014;2014:437803. doi: 10.1155/2014/437803. Epub 2014 Jul 09. PMID: 25170340; PMCID: PMC4120800.
Copy Download .nbib Format: NLM
'Tamsulosin and Darifenacin' Versus 'Tamsulosin Monotherapy' for 'BPH with Accompanying Overactive Bladder'.

Journal of clinical and diagnostic research : JCDR

Singh I, Agarwal V, Garg G.
PMID: 26266159
J Clin Diagn Res. 2015 Jun;9(6):PC08-11. doi: 10.7860/JCDR/2015/12526.6019. Epub 2015 Jun 01.

PURPOSE: To evaluate the efficacy/safety of 'tamsulosin and darifenacin' (TD) vs. 'tamsulosin and placebo' (TP) for patients with symptomatic benign prostrate hyperplasia (BPH) with accompanying overactive bladder (OAB) symptoms.MATERIALS AND METHODS: This study included symptomatic patients of BPH with...

Cite
Singh I, Agarwal V, Garg G. 'Tamsulosin and Darifenacin' Versus 'Tamsulosin Monotherapy' for 'BPH with Accompanying Overactive Bladder'. J Clin Diagn Res. 2015;9(6):PC08-11doi: 10.7860/JCDR/2015/12526.6019.
Singh, I., Agarwal, V., & Garg, G. (2015). 'Tamsulosin and Darifenacin' Versus 'Tamsulosin Monotherapy' for 'BPH with Accompanying Overactive Bladder'. Journal of clinical and diagnostic research : JCDR, 9(6), PC08-11. https://doi.org/10.7860/JCDR/2015/12526.6019
Singh, Iqbal, et al. "'Tamsulosin and Darifenacin' Versus 'Tamsulosin Monotherapy' for 'BPH with Accompanying Overactive Bladder'." Journal of clinical and diagnostic research : JCDR vol. 9,6 (2015): PC08-11. doi: https://doi.org/10.7860/JCDR/2015/12526.6019
Singh I, Agarwal V, Garg G. 'Tamsulosin and Darifenacin' Versus 'Tamsulosin Monotherapy' for 'BPH with Accompanying Overactive Bladder'. J Clin Diagn Res. 2015 Jun;9(6):PC08-11. doi: 10.7860/JCDR/2015/12526.6019. Epub 2015 Jun 01. PMID: 26266159; PMCID: PMC4525548.
Copy Download .nbib Format: NLM
Tamsulosin: ureteral stones (distal).

Hospital pharmacy

Rivard R.
PMID: 25684798
Hosp Pharm. 2015 Jan;50(1):31-3. doi: 10.1310/hjp5001-031.

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug...

Cite
Rivard R. Tamsulosin: ureteral stones (distal). Hosp Pharm. 2015;50(1):31-3doi: 10.1310/hjp5001-031.
Rivard, R. (2015). Tamsulosin: ureteral stones (distal). Hospital pharmacy, 50(1), 31-3. https://doi.org/10.1310/hjp5001-031
Rivard, Renée. "Tamsulosin: ureteral stones (distal)." Hospital pharmacy vol. 50,1 (2015): 31-3. doi: https://doi.org/10.1310/hjp5001-031
Rivard R. Tamsulosin: ureteral stones (distal). Hosp Pharm. 2015 Jan;50(1):31-3. doi: 10.1310/hjp5001-031. PMID: 25684798; PMCID: PMC4321426.
Copy Download .nbib Format: NLM
The effect of tamsulosin on pain and clearance according to ureteral stone location after shock wave lithotripsy.

Current therapeutic research, clinical and experimental

Basri Cakıroglu, Sinanoglu O, Mahmure Uraz.
PMID: 24385155
Curr Ther Res Clin Exp. 2013 Jun;74:33-5. doi: 10.1016/j.curtheres.2012.12.003.

BACKGROUND: Medical expulsion therapy has shown encouraging results in facilitating spontaneous clearance of ureteral stones after extracorporeal shock wave lithotripsy. However, no other study has yet determined the benefit of medical expulsion therapy for stones in different ureteral locations.OBJECTIVE:...

Cite
Basri Cakıroglu, Sinanoglu O, Mahmure Uraz. The effect of tamsulosin on pain and clearance according to ureteral stone location after shock wave lithotripsy. Curr Ther Res Clin Exp. 2013;74:33-5doi: 10.1016/j.curtheres.2012.12.003.
Basri Cakıroglu, Sinanoglu, O., & Mahmure Uraz. (2013). The effect of tamsulosin on pain and clearance according to ureteral stone location after shock wave lithotripsy. Current therapeutic research, clinical and experimental, 7433-5. https://doi.org/10.1016/j.curtheres.2012.12.003
Basri Cakıroglu, et al. "The effect of tamsulosin on pain and clearance according to ureteral stone location after shock wave lithotripsy." Current therapeutic research, clinical and experimental vol. 74 (2013): 33-5. doi: https://doi.org/10.1016/j.curtheres.2012.12.003
Basri Cakıroglu, Sinanoglu O, Mahmure Uraz. The effect of tamsulosin on pain and clearance according to ureteral stone location after shock wave lithotripsy. Curr Ther Res Clin Exp. 2013 Jun;74:33-5. doi: 10.1016/j.curtheres.2012.12.003. PMID: 24385155; PMCID: PMC3862193.
Copy Download .nbib Format: NLM
Efficacy of Dose Escalation of Tamsulosin for the Treatment of Lower Urinary Tract Symptoms.

Lower urinary tract symptoms

Kim JW, Oh MM, Yeo JK, Bae JH, Joo KJ, Choi JB, Park HS, Kim HJ, Moon du G, Lee JG.
PMID: 26676533
Low Urin Tract Symptoms. 2012 May;4(2):96-102. doi: 10.1111/j.1757-5672.2012.00141.x. Epub 2012 Feb 17.

OBJECTIVES: The aim of this study was to compare the efficacy of low (0.2 mg) and intermediate (0.4 mg) dose tamsulosin in treating lower urinary tract symptoms (LUTS).METHODS: Patients were treated with low-dose tamsulosin for an initial run-in period...

Cite
Kim JW, Oh MM, Yeo JK, et al. Efficacy of Dose Escalation of Tamsulosin for the Treatment of Lower Urinary Tract Symptoms. Low Urin Tract Symptoms. 2012;4(2):96-102doi: 10.1111/j.1757-5672.2012.00141.x.
Kim, J. W., Oh, M. M., Yeo, J. K., Bae, J. H., Joo, K. J., Choi, J. B., Park, H. S., Kim, H. J., Moon, d. u. . G., & Lee, J. G. (2012). Efficacy of Dose Escalation of Tamsulosin for the Treatment of Lower Urinary Tract Symptoms. Lower urinary tract symptoms, 4(2), 96-102. https://doi.org/10.1111/j.1757-5672.2012.00141.x
Kim, Jin Wook, et al. "Efficacy of Dose Escalation of Tamsulosin for the Treatment of Lower Urinary Tract Symptoms." Lower urinary tract symptoms vol. 4,2 (2012): 96-102. doi: https://doi.org/10.1111/j.1757-5672.2012.00141.x
Kim JW, Oh MM, Yeo JK, Bae JH, Joo KJ, Choi JB, Park HS, Kim HJ, Moon du G, Lee JG. Efficacy of Dose Escalation of Tamsulosin for the Treatment of Lower Urinary Tract Symptoms. Low Urin Tract Symptoms. 2012 May;4(2):96-102. doi: 10.1111/j.1757-5672.2012.00141.x. Epub 2012 Feb 17. PMID: 26676533.
Copy Download .nbib Format: NLM
Minimal Rectal Toxicity in the Setting of Comorbid Crohn's Disease Following Prostate Cancer Radiotherapy with a Hydrogel Rectal Spacer.

Cureus

Singh R, Jackson PS, Blake M, Cutlip J, Sharma S.
PMID: 28983442
Cureus. 2017 Aug 01;9(8):e1533. doi: 10.7759/cureus.1533.

We present one of the first cases of a prostate cancer (PCa) patient with inflammatory bowel disease (IBD) treated with intensity-modulated radiotherapy (IMRT) and a hydrogel rectal spacer. A 73-year-old male with a past medical history significant for Crohn's...

Cite
Singh R, Jackson PS, Blake M, et al. Minimal Rectal Toxicity in the Setting of Comorbid Crohn's Disease Following Prostate Cancer Radiotherapy with a Hydrogel Rectal Spacer. Cureus. 2017;9(8):e1533doi: 10.7759/cureus.1533.
Singh, R., Jackson, P. S., Blake, M., Cutlip, J., & Sharma, S. (2017). Minimal Rectal Toxicity in the Setting of Comorbid Crohn's Disease Following Prostate Cancer Radiotherapy with a Hydrogel Rectal Spacer. Cureus, 9(8), e1533. https://doi.org/10.7759/cureus.1533
Singh, Raj, et al. "Minimal Rectal Toxicity in the Setting of Comorbid Crohn's Disease Following Prostate Cancer Radiotherapy with a Hydrogel Rectal Spacer." Cureus vol. 9,8 (2017): e1533. doi: https://doi.org/10.7759/cureus.1533
Singh R, Jackson PS, Blake M, Cutlip J, Sharma S. Minimal Rectal Toxicity in the Setting of Comorbid Crohn's Disease Following Prostate Cancer Radiotherapy with a Hydrogel Rectal Spacer. Cureus. 2017 Aug 01;9(8):e1533. doi: 10.7759/cureus.1533. PMID: 28983442; PMCID: PMC5624568.
Copy Download .nbib Format: NLM
Severe hypotension during general anesthesia in a patient on chronic high-dose Tamsulosin therapy.

Anesthesia, essays and researches

Chauhan G, Gupta K, Nayar P.
PMID: 25885851
Anesth Essays Res. 2013 May-Aug;7(2):285-6. doi: 10.4103/0259-1162.118985.

No abstract available.

Cite
Chauhan G, Gupta K, Nayar P. Severe hypotension during general anesthesia in a patient on chronic high-dose Tamsulosin therapy. Anesth Essays Res. 2013;7(2):285-6doi: 10.4103/0259-1162.118985.
Chauhan, G., Gupta, K., & Nayar, P. (2013). Severe hypotension during general anesthesia in a patient on chronic high-dose Tamsulosin therapy. Anesthesia, essays and researches, 7(2), 285-6. https://doi.org/10.4103/0259-1162.118985
Chauhan, Gaurav, et al. "Severe hypotension during general anesthesia in a patient on chronic high-dose Tamsulosin therapy." Anesthesia, essays and researches vol. 7,2 (2013): 285-6. doi: https://doi.org/10.4103/0259-1162.118985
Chauhan G, Gupta K, Nayar P. Severe hypotension during general anesthesia in a patient on chronic high-dose Tamsulosin therapy. Anesth Essays Res. 2013 May-Aug;7(2):285-6. doi: 10.4103/0259-1162.118985. PMID: 25885851; PMCID: PMC4173516.
Copy Download .nbib Format: NLM
Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial.

Arab journal of urology

Fawzi A, Kamel M, Salem E, Desoky E, Omran M, Elgalaly H, Sakr A, Maarouf A, Khalil S.
PMID: 28275519
Arab J Urol. 2016 Dec 29;15(1):53-59. doi: 10.1016/j.aju.2016.11.001. eCollection 2017 Mar.

OBJECTIVE: To assess the additive effect of sildenafil citrate to tamsulosin in the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia (LUTS/BPH) in men with or without erectile dysfunction (ED).PATIENTS AND METHODS: In all, 150 men...

Cite
Fawzi A, Kamel M, Salem E, et al. Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial. Arab J Urol. 2016;15(1):53-59doi: 10.1016/j.aju.2016.11.001.
Fawzi, A., Kamel, M., Salem, E., Desoky, E., Omran, M., Elgalaly, H., Sakr, A., Maarouf, A., & Khalil, S. (2017). Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial. Arab journal of urology, 15(1), 53-59. https://doi.org/10.1016/j.aju.2016.11.001
Fawzi, Amr, et al. "Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial." Arab journal of urology vol. 15,1 (2017): 53-59. doi: https://doi.org/10.1016/j.aju.2016.11.001
Fawzi A, Kamel M, Salem E, Desoky E, Omran M, Elgalaly H, Sakr A, Maarouf A, Khalil S. Sildenafil citrate in combination with tamsulosin versus tamsulosin monotherapy for management of male lower urinary tract symptoms due to benign prostatic hyperplasia: A randomised, double-blind, placebo-controlled trial. Arab J Urol. 2016 Dec 29;15(1):53-59. doi: 10.1016/j.aju.2016.11.001. eCollection 2017 Mar. PMID: 28275519; PMCID: PMC5329701.
Copy Download .nbib Format: NLM
A Randomized Controlled Trial to Compare the Safety and Efficacy of Tadalafil and Tamsulosin in Relieving Double J Stent Related Symptoms.

Advances in urology

Aggarwal SP, Priyadarshi S, Tomar V, Yadav SS, Gangkak G, Vyas N, Agarwal N, Kumar U.
PMID: 26788054
Adv Urol. 2015;2015:592175. doi: 10.1155/2015/592175. Epub 2015 Dec 14.

Objectives. To evaluate the safety and efficacy of Tadalafil and Tamsulosin in treating Double J stent related symptoms. Methods. In a prospective study, 161 patients with DJ related symptoms were randomized into 3 groups: Group A patients (54), Group...

Cite
Aggarwal SP, Priyadarshi S, Tomar V, et al. A Randomized Controlled Trial to Compare the Safety and Efficacy of Tadalafil and Tamsulosin in Relieving Double J Stent Related Symptoms. Adv Urol. 2015;2015:592175doi: 10.1155/2015/592175.
Aggarwal, S. P., Priyadarshi, S., Tomar, V., Yadav, S. S., Gangkak, G., Vyas, N., Agarwal, N., & Kumar, U. (2015). A Randomized Controlled Trial to Compare the Safety and Efficacy of Tadalafil and Tamsulosin in Relieving Double J Stent Related Symptoms. Advances in urology, 2015592175. https://doi.org/10.1155/2015/592175
Aggarwal, Satinder Pal, et al. "A Randomized Controlled Trial to Compare the Safety and Efficacy of Tadalafil and Tamsulosin in Relieving Double J Stent Related Symptoms." Advances in urology vol. 2015 (2015): 592175. doi: https://doi.org/10.1155/2015/592175
Aggarwal SP, Priyadarshi S, Tomar V, Yadav SS, Gangkak G, Vyas N, Agarwal N, Kumar U. A Randomized Controlled Trial to Compare the Safety and Efficacy of Tadalafil and Tamsulosin in Relieving Double J Stent Related Symptoms. Adv Urol. 2015;2015:592175. doi: 10.1155/2015/592175. Epub 2015 Dec 14. PMID: 26788054; PMCID: PMC4691600.
Copy Download .nbib Format: NLM
alpha(1)-Blocker therapy in the nineties: focus on the disease.

Prostate cancer and prostatic diseases

Höfner K.
PMID: 12496768
Prostate Cancer Prostatic Dis. 1999 Dec;2:S9-S15. doi: 10.1038/sj.pcan.4500368.

Therapy for benign prostatic hyperplasia has evolved rapidly over the last decade, with the introduction in the early 1990s of new agents such as alpha(1)-blockers and 5alpha-reductase inhibitors. The major advantage of alpha(1)-blockers over 5alpha-reductase inhibitors is their rapid...

Cite
Höfner K. alpha(1)-Blocker therapy in the nineties: focus on the disease. Prostate Cancer Prostatic Dis. 1999;2:S9-S15doi: 10.1038/sj.pcan.4500368.
Höfner, K. (1999). alpha(1)-Blocker therapy in the nineties: focus on the disease. Prostate cancer and prostatic diseases, 2S9-S15. https://doi.org/10.1038/sj.pcan.4500368
Höfner, K. "alpha(1)-Blocker therapy in the nineties: focus on the disease." Prostate cancer and prostatic diseases vol. 2 (1999): S9-S15. doi: https://doi.org/10.1038/sj.pcan.4500368
Höfner K. alpha(1)-Blocker therapy in the nineties: focus on the disease. Prostate Cancer Prostatic Dis. 1999 Dec;2:S9-S15. doi: 10.1038/sj.pcan.4500368. PMID: 12496768.
Copy Download .nbib Format: NLM
Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology

Bayés M, Rabasseda X, Prous JR.
PMID: 12616965
Methods Find Exp Clin Pharmacol. 2002 Dec;24(10):703-29.

Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the following tables has been retrieved from the Clinical Studies knowledge area of Prous Science Integrity, the drug...

Cite
Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2002;24(10):703-29
Bayés, M., Rabasseda, X., & Prous, J. R. (2002). Gateways to clinical trials. Methods and findings in experimental and clinical pharmacology, 24(10), 703-29.
Bayés, M, et al. "Gateways to clinical trials." Methods and findings in experimental and clinical pharmacology vol. 24,10 (2002): 703-29.
Bayés M, Rabasseda X, Prous JR. Gateways to clinical trials. Methods Find Exp Clin Pharmacol. 2002 Dec;24(10):703-29. PMID: 12616965.
Copy Download .nbib Format: NLM
Alpha-blocker therapy for benign prostatic hyperplasia: a comparative review.

The Canadian journal of urology

Goldenberg SL, Ramsey E, Trachtenberg J.
PMID: 11299113
Can J Urol. 1998 Jun;5(2):551-557.

In the past decade there has been a shift in the primary approach to therapy for BPH, from surgical intervention to pharmacotherapy. Therapies with alpha-blockers, particularly long-acting selective alpha1-adrenoreceptor antagonists, has proven effective, and hence has become a popular...

Cite
Goldenberg SL, Ramsey E, Trachtenberg J. Alpha-blocker therapy for benign prostatic hyperplasia: a comparative review. Can J Urol. 1998;5(2):551-557
Goldenberg, S. L., Ramsey, E., & Trachtenberg, J. (1998). Alpha-blocker therapy for benign prostatic hyperplasia: a comparative review. The Canadian journal of urology, 5(2), 551-557.
Goldenberg, S. Larry, et al. "Alpha-blocker therapy for benign prostatic hyperplasia: a comparative review." The Canadian journal of urology vol. 5,2 (1998): 551-557.
Goldenberg SL, Ramsey E, Trachtenberg J. Alpha-blocker therapy for benign prostatic hyperplasia: a comparative review. Can J Urol. 1998 Jun;5(2):551-557. PMID: 11299113.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 325 entries